Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...
A groundbreaking blood test, HPV-DeepSeek, developed by Mass General Brigham researchers, offers early detection of ...
The American Society for Colposcopy and Cervical Pathology (ASCCP) has issued new guidelines reflecting the importance of extended genotyping in HPV testing to support an enhanced standard of patient ...
A new liquid biopsy blood test could help detect cases of human papillomavirus (HPV)-associated head and neck cancers with significantly higher accuracy than currently used methods, including before ...
Mel-Mont Medical, a women's health diagnostics company advancing accessible cervical cancer screening through HPV-positive patient risk assessment, announced today that it was recognized at the 2026 ...
Cervical cancer remains a leading cause of cancer-related death among women globally, despite the availability of effective prevention through human papillomavirus (HPV) vaccination and HPV-based ...
These are the FDA-approved options to test for prostate, colorectal, and cervical cancer.